IndraLab
Statements
reach
"This mutant panel affects proteins for key pathways of RNA processing and degradation: Rrp6, a 3′-5′ exonuclease of the nuclear RNA exosome (Harigaya et al. 2006; Lemay et al. 2014); Dis3, a 3′-5′ exo/endonuclease of the core RNA exosome (Wang et al. 2008); Ago1 (Argonaute), Dcr1 (RNase III-like Dicer), and Rdp1 (RNA-dependent RNA polymerase) of the RNAi pathway (Volpe et al. 2002); Exo2, a cytoplasmic 5′ exonuclease (ortholog of XRN1) (Houseley and Tollervey 2009); Ski7, a cytoplasmic cofactor which links the Ski complex to the exosome (Lemay et al. 2010); Cid14, a poly(A) polymerase of the TRAMP complex which is a cofactor of the nuclear RNA exosome (Wang et al. 2008); Pab2, a poly(A)-binding protein targeting RNAs to the nuclear exosome (PABPN1 ortholog) (Lemieux et al. 2011); Pan2, a deadenylase of the Pan2–Pan3 complex (Wolf and Passmore 2014); and Upf1, an ATP-dependent RNA helicase of the NMD pathway (Rodríguez-Gabriel et al. 2006)."
reach
"However, it has been proved that miRISC consists of many other components: GW182 proteins (a family of proteins rich in tryptophan and glycine repeats, specifically TNRC6A-C in humans), the CCR4-NOT complex (carbon catabolite repression—negative on TATA-less complex), the PAN2/PAN3 complex (two subunits of the poly(A)-specific ribonuclease PAN complex), DCP1 (decapping protein 1), DDX6 (RNA helicase), and GIGYF2 (GRB10 interacting GYF protein 2)."
reach
"Deadenylases may act in multi-subunit complexes, such as the carbon catabolite repressor protein 4 (CCR4)-negative on TATA (NOT) complex (CCR4–NOT or CNOT) [3], in heterocomplexes, including the Pan2–Pan3 complex consisting of a 1:2 stoichiometry [4,5], and oligomeric, such as the poly(A)-specific ribonuclease (PARN) [6,7]."
reach
"The poly(A) tail recruits PAN2–PAN3 through at least three interactions: between the PAN3 N-terminal zinc finger and adenosines in the poly(A) tail; between PAN3 and a PAM2 motif in PABP; and between additional regions of the PAN2–PAN3 complex and the PABPC–poly(A) RNP [12,52,118]."
reach
"The mechanism by which miRNA takes effect is through inhibition of translation assembly: miRNA competes with eIF4E at the m7G cap site of the mRNA, while promoting deadenylation, decapping, and degradation of the mRNA through recruitment of the PAN2-PAN3 complex, the CCR-NOT complex, and exoribonuclease 1 (XRN1) (Kargutkar et al., 2023)."